VANGUARD GROUP INC - Mar 31, 2025 Form SCHEDULE 13G/A Schedule Report for Alnylam Pharmaceuticals Inc (ALNY)

Filing Manager: VANGUARD GROUP INC
Reporting Manager: The Vanguard Group
Security: Alnylam Pharmaceuticals Inc Common Stock
Symbol: ALNY
Shares outstanding: 130M shares
Disclosed Ownership: 13.1M shares
Ownership: 10%
Form type: SCHEDULE 13G/A
Date filed: 4/7/2025, 11:51 AM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
The Vanguard Group	10.03%	13.1M	0	100K	Ashley Grim	Head of Global Fund Administration